Accessibility Menu
 

Why Teva Pharmaceutical and Under Armour Are Looking So Unhealthy

The world's top generic-drug maker just suffered through a week that saw the market trim its value by about one-third. Meanwhile, the athletic gear upstart is down by half in the past year.

By Motley Fool Staff Aug 8, 2017 at 3:54PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.